310 related articles for article (PubMed ID: 26574786)
21. Treatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.
Ronson A; Tvito A; Rowe JM
Curr Treat Options Oncol; 2017 Mar; 18(3):20. PubMed ID: 28382538
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor.
Togasaki E; Shono K; Onoda M; Yokota A
Leuk Lymphoma; 2015 Jan; 56(1):244-7. PubMed ID: 24730539
[No Abstract] [Full Text] [Related]
23. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.
Yilmaz M; Kantarjian H; Ravandi-Kashani F; Short NJ; Jabbour E
Clin Adv Hematol Oncol; 2018 Mar; 16(3):216-223. PubMed ID: 29742077
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of adult Ph-negative acute lymphoblastic leukemia].
Imai K
Rinsho Ketsueki; 2014 Oct; 55(10):1962-71. PubMed ID: 25297761
[No Abstract] [Full Text] [Related]
25. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?
Litzow MR
Best Pract Res Clin Haematol; 2018 Dec; 31(4):357-360. PubMed ID: 30466747
[TBL] [Abstract][Full Text] [Related]
27. [Recent advances in oncology. Acute lymphoblastic leukemia in children].
Sommelet D
Arch Fr Pediatr; 1991 Nov; 48(9):657-63. PubMed ID: 1763938
[No Abstract] [Full Text] [Related]
28. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G
Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733
[No Abstract] [Full Text] [Related]
29. Philadelphia chromosome positive acute lymphoblastic leukemia masquerading as persistent asymptomatic bone marrow necrosis.
Kwong YL; Pollock A; Wei D; Lie AK
Pathology; 1994 Apr; 26(2):183-5. PubMed ID: 8090591
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.
Ottmann O
Lancet Haematol; 2018 Dec; 5(12):e606-e607. PubMed ID: 30501865
[No Abstract] [Full Text] [Related]
31. Current and future management of Ph/BCR-ABL positive ALL.
Maino E; Sancetta R; Viero P; Imbergamo S; Scattolin AM; Vespignani M; Bassan R
Expert Rev Anticancer Ther; 2014 Jun; 14(6):723-40. PubMed ID: 24611626
[TBL] [Abstract][Full Text] [Related]
32. The emerging use of chemotherapy-free regimens in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sawyers JD; Jammal NJ; Short NJ; Kantarjian H; Jabbour EJ
Clin Adv Hematol Oncol; 2023 Feb; 21(2):68-75. PubMed ID: 36780472
[TBL] [Abstract][Full Text] [Related]
33. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patients.
Short NJ; Jabbour E
Clin Adv Hematol Oncol; 2016 Nov; 14(11):892-894. PubMed ID: 27930640
[No Abstract] [Full Text] [Related]
34. Advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Stock W
Clin Adv Hematol Oncol; 2008 Jul; 6(7):487-8. PubMed ID: 18654114
[No Abstract] [Full Text] [Related]
35. Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Gruber F; Mustjoki S; Porkka K
Br J Haematol; 2009 Jun; 145(5):581-97. PubMed ID: 19388927
[TBL] [Abstract][Full Text] [Related]
36. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
[TBL] [Abstract][Full Text] [Related]
37. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is not necessary, at least in induction.
Chiaretti S
Clin Adv Hematol Oncol; 2016 Nov; 14(11):892-896. PubMed ID: 27930641
[No Abstract] [Full Text] [Related]
38. CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kong Y; Chang YJ; Liu YR; Wang YZ; Jiang Q; Jiang H; Qin YZ; Hu Y; Lai YY; Duan CW; Hong DL; Huang XJ
Leukemia; 2014 Dec; 28(12):2398-401. PubMed ID: 25135692
[No Abstract] [Full Text] [Related]
39. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
40. Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.
Ma Y; Zhang Q; Kong P; Xiong J; Zhang X; Zhang C
Chemotherapy; 2019; 64(2):81-93. PubMed ID: 31390613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
